Velteve
Trademark details
Velteve® is a registered trademark used for Pharmaceutical Preparations and Substances For the Treatment of Infectious Diseases, Pain, Inflammation, Sepsis, Alopecia and Obesity, and For the Treatment of Viral, Metabolic, Musculoskeletal, Cardiovascular, Cardiopulmonary, Genitourinary, Sexual Dysfunction, Oncological, Respiratory, Neurological, Gastrointestinal, Hormonal, Dermatological and Psychiatric Related Diseases and Disorders and For the Treatment of Damaged Skin and Tissue and owned by Glaxo Group Limited. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Pharmaceutical Preparations and Substances For the Treatment of Infectious Diseases, Pain, Inflammation, Sepsis, Alopecia and Obesity, and For the Treatment of Viral, Metabolic, Musculoskeletal, Cardiovascular, Cardiopulmonary, Genitourinary, Sexual Dysfunction, Oncological, Respiratory, Neurological, Gastrointestinal, Hormonal, Dermatological and Psychiatric Related Diseases and Disorders and For the Treatment of Damaged Skin and Tissue and For Vaccines |
| Serial Number: | 78607629 |
| Registration Number: | 3092733 |
| Filing Date: | Apr 13, 2005 |
|
Last Applicant(s)/ Owner(s) of Record | Glaxo Group LimitedGlaxo Wellcome House |
| Related Products: | Pharmaceuticals |
Web Sites
powered by 
Total : 40 View more »
midnight velvet outlet - BuyCheapr.com
midnight velvet outlet - compare prices at BuyCheapr.com ... help Star Legacy's Midnight Radiance Heart is a stunning memorial, majestic in its appearance.
Full text of "Denkschriften der Königlichen Akademie der ...
Full text of "Denkschriften der Königlichen Akademie der Wissenschaften zu München für das Jahr.."
Taal in Nederland .:. Brabants
In een enkel geval was onbekend welke naam de meest oorspronkelijke was (Vèèltóvve naast Vèlteve voor Veldhoven) en hebben we simpelweg een keuze gemaakt.
Rommelgat
De start- en finish madde zelluf kieze, Oers, Velteve, Zilst of Mirvelteve, ut makt nie uit. We gaon er vur! Door: SOK PR & Communicatie | Geplaatst: 8 februari 2012
